Patients With Higher BMI Produces More Postoperative Drainage Volume and Length of Stay in Cross-Sectional Study

August 16, 2023 updated by: Ludwig Andre Pontoh, Indonesia University

Patients With Higher BMI Produces More Postoperative Drainage Volume and Longer Length of Stay in Cross-Sectional Study: a Comparison of Total vs Partial Knee Arthroplasty

Partial knee arthroplasty theoretically produces less blood loss compared to total knee arthroplasty (TKA) due to a lesser invasive procedure. Medial unicompartmental knee arthroplasty (UKA) is the most common partial knee arthroplasty performed due used due to the most commonly impacted medial knee. This study compared the postoperative drainage volume and length of stay (LOS) of TKA vs UKA and evaluated its comparison with patient characteristics.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Theoretically, UKA will produce less blood loss due to a shorter skin incision, quadriceps sparing muscle approach, persistence of cruciate ligaments, and less femorotibial dislocation.7 However, studies investigating drainage volume in UKA are still limited. In this study, we compared the drainage volume of patients undergoing TKA vs UKA and evaluated several parameters that contributed the production. This study has not received any funding or grant.

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jakarta, Indonesia
        • Pondok Indah Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

medical records of patients who underwent primary TKA and UKA between December 2019 and October 2022

Description

Inclusion Criteria:

  • grade 4 Osteoarthritis

Exclusion Criteria:

  • previous trauma
  • infection
  • blood coagulation disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TKA (Total Knee Arthroplasty) procedure
Total Knee Arthroplasty
Total vs Partial Knee Replacement
UKA (Uni Knee Arthroplasty) procedure
Uni Knee Arthroplasty
Total vs Partial Knee Replacement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Drainage Volume
Time Frame: 3-5 days post op
total drainage volume
3-5 days post op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
LOS
Time Frame: pre-op until drainage removed, 3-6 days post op
length of stay
pre-op until drainage removed, 3-6 days post op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ismail H Dilogo, Prof, Indonesia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 23, 2019

Primary Completion (Actual)

October 21, 2022

Study Completion (Actual)

December 7, 2022

Study Registration Dates

First Submitted

August 9, 2023

First Submitted That Met QC Criteria

August 16, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 16, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 23082020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe